1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Samuel, D.
Cheng, H.
Riley, P.W.
Canutescu, A.A.
Bu, Z.
Walsh, P.N.
Roder, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
104
15693
10.1073/PNAS.0703080104
17884987
Solution Structure of the A4 Domain of Factor Xi Sheds Light on the Mechanism of Zymogen Activation.
2007
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
9958.274
COAGULATION FACTOR XI
3.4.21.27
APPLE 4 DOMAIN, RESIDUES 290-379
2
nat
polymer
PLASMA THROMBOPLASTIN ANTECEDENT, PTA, FXI, FACTOR XI
no
no
FCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGY
TLRLCKMDNE
FCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGY
TLRLCKMDNE
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
repository
Initial release
Version format compliance
Version format compliance
1
0
2007-10-02
1
1
2011-05-08
1
2
2011-07-13
CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEXWITH ECOTINM84R
CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEXWITH MUTATED ECOTIN
CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEXWITH ECOTIN MUTANT (ECOTINP)
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THECOAGULATION FACTOR XIA IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K437 MUTANT)
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K505MUTANT)
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-C482S-K437A MUTANT)
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH KUNITZ PROTEASE INHIBITOR DOMAINOF PROTEASE NEXIN II
FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH 2 -GUANIDINO-1-(4-(4,4,5,5-TETRAMETHYL-1 ,3,2-DIOXABOROLAN-2-YL)PHENYL) ETHYLNICOTINATE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI INCOMPLEX WITH 4-(GUANIDINOMETHYL )-PHENYLBORONIC ACID
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI INCOMPLEX WITH (R)-1-(4-(4-( HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL) PHENETHYL)GUANIDINE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH (R)-1 -(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN- 2-YL)PHENYL)GUANIDINE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR
FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH N -((R)-1-(4-BROMOPHENYL)ETHYL)UREA-ASN-VAL -ARG-ALPHA-KETOTHIAZOLE
FACTOR XI COMPLEXED WITH 3-HYDROXYPROPYL 3 -(7-AMIDINONAPHTHALENE-1-CARBOXAMIDO) BENZENESULFONATE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH N-(7 -CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2 -METHYL-BENZAMIDE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH 6- CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYLESTER
FACTOR XI COMPLEXED WITH A PYRIMIDINONE INHIBITOR
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH 2-(5 -BENZYLAMINO-2-METHYLSULFANYL-6-OXO-6H- PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE -2-CARBONYL)-BUTYL]-ACETAMIDE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH 2-(5 -AMINO-6-OXO-2-M-TOLYL-6H-PYRIMIDIN-1- YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL )-BUTYL]-ACETAMIDE
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH N-[4 -GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-2 -{6-OXO-5-[(QUINOLIN-8-YLMETHYL)-AMINO]-2 -M-TOLYL-6H-PYRIMIDIN-1-YL}-ACETAMIDE
SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI
PDBE
Y
PDBE
2006-10-25
REL
SIDE-CHAIN ASSIGNMENTS WERE OBTAINED FROM 3D-15N TOCSY-HSQC AND 3D-HCCH-TOCSY . DISTANCE RESTRAINTS WERE OBTAINED FROM CROSS-PEAK VOLUMES IN 3D 15N NOESY-HSQC , 3D- 13C-EDITED NOESY AND HOMONUCLEAR NOESY
NO RESTRAINT VIOLATION AND LOWEST ENERGY
1
14
NOESY
COSY
HNHA
CBCANH
CBCACONH
6.2
pH
310.0
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
CNS
1
90% WATER/10% D2O
BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE,SIMONSON,WARREN
refinement
CNS
structure solution
CNS
600
Bruker
DMX
PHE
272
n
1
PHE
272
A
CYS
273
n
2
CYS
273
A
HIS
274
n
3
HIS
274
A
SER
275
n
4
SER
275
A
SER
276
n
5
SER
276
A
PHE
277
n
6
PHE
277
A
TYR
278
n
7
TYR
278
A
HIS
279
n
8
HIS
279
A
ASP
280
n
9
ASP
280
A
THR
281
n
10
THR
281
A
ASP
282
n
11
ASP
282
A
PHE
283
n
12
PHE
283
A
LEU
284
n
13
LEU
284
A
GLY
285
n
14
GLY
285
A
GLU
286
n
15
GLU
286
A
GLU
287
n
16
GLU
287
A
LEU
288
n
17
LEU
288
A
ASP
289
n
18
ASP
289
A
ILE
290
n
19
ILE
290
A
VAL
291
n
20
VAL
291
A
ALA
292
n
21
ALA
292
A
ALA
293
n
22
ALA
293
A
LYS
294
n
23
LYS
294
A
SER
295
n
24
SER
295
A
HIS
296
n
25
HIS
296
A
GLU
297
n
26
GLU
297
A
ALA
298
n
27
ALA
298
A
CYS
299
n
28
CYS
299
A
GLN
300
n
29
GLN
300
A
LYS
301
n
30
LYS
301
A
LEU
302
n
31
LEU
302
A
CYS
303
n
32
CYS
303
A
THR
304
n
33
THR
304
A
ASN
305
n
34
ASN
305
A
ALA
306
n
35
ALA
306
A
VAL
307
n
36
VAL
307
A
ARG
308
n
37
ARG
308
A
CYS
309
n
38
CYS
309
A
GLN
310
n
39
GLN
310
A
PHE
311
n
40
PHE
311
A
PHE
312
n
41
PHE
312
A
THR
313
n
42
THR
313
A
TYR
314
n
43
TYR
314
A
THR
315
n
44
THR
315
A
PRO
316
n
45
PRO
316
A
ALA
317
n
46
ALA
317
A
GLN
318
n
47
GLN
318
A
ALA
319
n
48
ALA
319
A
SER
320
n
49
SER
320
A
CYS
321
n
50
CYS
321
A
ASN
322
n
51
ASN
322
A
GLU
323
n
52
GLU
323
A
GLY
324
n
53
GLY
324
A
LYS
325
n
54
LYS
325
A
GLY
326
n
55
GLY
326
A
LYS
327
n
56
LYS
327
A
CYS
328
n
57
CYS
328
A
TYR
329
n
58
TYR
329
A
LEU
330
n
59
LEU
330
A
LYS
331
n
60
LYS
331
A
LEU
332
n
61
LEU
332
A
SER
333
n
62
SER
333
A
SER
334
n
63
SER
334
A
ASN
335
n
64
ASN
335
A
GLY
336
n
65
GLY
336
A
SER
337
n
66
SER
337
A
PRO
338
n
67
PRO
338
A
THR
339
n
68
THR
339
A
LYS
340
n
69
LYS
340
A
ILE
341
n
70
ILE
341
A
LEU
342
n
71
LEU
342
A
HIS
343
n
72
HIS
343
A
GLY
344
n
73
GLY
344
A
ARG
345
n
74
ARG
345
A
GLY
346
n
75
GLY
346
A
GLY
347
n
76
GLY
347
A
ILE
348
n
77
ILE
348
A
SER
349
n
78
SER
349
A
GLY
350
n
79
GLY
350
A
TYR
351
n
80
TYR
351
A
THR
352
n
81
THR
352
A
LEU
353
n
82
LEU
353
A
ARG
354
n
83
ARG
354
A
LEU
355
n
84
LEU
355
A
CYS
356
n
85
CYS
356
A
LYS
357
n
86
LYS
357
A
MET
358
n
87
MET
358
A
ASP
359
n
88
ASP
359
A
ASN
360
n
89
ASN
360
A
GLU
361
n
90
GLU
361
A
PHE
272
n
1
PHE
272
B
CYS
273
n
2
CYS
273
B
HIS
274
n
3
HIS
274
B
SER
275
n
4
SER
275
B
SER
276
n
5
SER
276
B
PHE
277
n
6
PHE
277
B
TYR
278
n
7
TYR
278
B
HIS
279
n
8
HIS
279
B
ASP
280
n
9
ASP
280
B
THR
281
n
10
THR
281
B
ASP
282
n
11
ASP
282
B
PHE
283
n
12
PHE
283
B
LEU
284
n
13
LEU
284
B
GLY
285
n
14
GLY
285
B
GLU
286
n
15
GLU
286
B
GLU
287
n
16
GLU
287
B
LEU
288
n
17
LEU
288
B
ASP
289
n
18
ASP
289
B
ILE
290
n
19
ILE
290
B
VAL
291
n
20
VAL
291
B
ALA
292
n
21
ALA
292
B
ALA
293
n
22
ALA
293
B
LYS
294
n
23
LYS
294
B
SER
295
n
24
SER
295
B
HIS
296
n
25
HIS
296
B
GLU
297
n
26
GLU
297
B
ALA
298
n
27
ALA
298
B
CYS
299
n
28
CYS
299
B
GLN
300
n
29
GLN
300
B
LYS
301
n
30
LYS
301
B
LEU
302
n
31
LEU
302
B
CYS
303
n
32
CYS
303
B
THR
304
n
33
THR
304
B
ASN
305
n
34
ASN
305
B
ALA
306
n
35
ALA
306
B
VAL
307
n
36
VAL
307
B
ARG
308
n
37
ARG
308
B
CYS
309
n
38
CYS
309
B
GLN
310
n
39
GLN
310
B
PHE
311
n
40
PHE
311
B
PHE
312
n
41
PHE
312
B
THR
313
n
42
THR
313
B
TYR
314
n
43
TYR
314
B
THR
315
n
44
THR
315
B
PRO
316
n
45
PRO
316
B
ALA
317
n
46
ALA
317
B
GLN
318
n
47
GLN
318
B
ALA
319
n
48
ALA
319
B
SER
320
n
49
SER
320
B
CYS
321
n
50
CYS
321
B
ASN
322
n
51
ASN
322
B
GLU
323
n
52
GLU
323
B
GLY
324
n
53
GLY
324
B
LYS
325
n
54
LYS
325
B
GLY
326
n
55
GLY
326
B
LYS
327
n
56
LYS
327
B
CYS
328
n
57
CYS
328
B
TYR
329
n
58
TYR
329
B
LEU
330
n
59
LEU
330
B
LYS
331
n
60
LYS
331
B
LEU
332
n
61
LEU
332
B
SER
333
n
62
SER
333
B
SER
334
n
63
SER
334
B
ASN
335
n
64
ASN
335
B
GLY
336
n
65
GLY
336
B
SER
337
n
66
SER
337
B
PRO
338
n
67
PRO
338
B
THR
339
n
68
THR
339
B
LYS
340
n
69
LYS
340
B
ILE
341
n
70
ILE
341
B
LEU
342
n
71
LEU
342
B
HIS
343
n
72
HIS
343
B
GLY
344
n
73
GLY
344
B
ARG
345
n
74
ARG
345
B
GLY
346
n
75
GLY
346
B
GLY
347
n
76
GLY
347
B
ILE
348
n
77
ILE
348
B
SER
349
n
78
SER
349
B
GLY
350
n
79
GLY
350
B
TYR
351
n
80
TYR
351
B
THR
352
n
81
THR
352
B
LEU
353
n
82
LEU
353
B
ARG
354
n
83
ARG
354
B
LEU
355
n
84
LEU
355
B
CYS
356
n
85
CYS
356
B
LYS
357
n
86
LYS
357
B
MET
358
n
87
MET
358
B
ASP
359
n
88
ASP
359
B
ASN
360
n
89
ASN
360
B
GLU
361
n
90
GLU
361
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
278
A
N
TYR
7
A
O
SER
349
A
O
SER
78
A
N
GLY
350
A
N
GLY
79
A
O
PHE
312
A
O
PHE
41
A
N
THR
315
A
N
THR
44
A
O
LYS
327
A
O
LYS
56
A
N
LEU
330
A
N
LEU
59
A
O
ASP
289
A
O
ASP
18
A
N
LEU
284
A
N
LEU
13
A
O
LYS
340
A
O
LYS
69
B
N
TYR
278
B
N
TYR
7
B
O
SER
349
B
O
SER
78
B
N
GLY
350
B
N
GLY
79
B
O
PHE
312
B
O
PHE
41
B
N
THR
313
B
N
THR
42
B
O
TYR
329
B
O
TYR
58
B
N
LEU
332
B
N
LEU
61
B
O
GLU
287
B
O
GLU
16
B
N
LEU
284
B
N
LEU
13
B
O
LYS
340
B
O
LYS
69
1
A
A
HA
HB2
PHE
TYR
311
351
1.19
1
B
B
HH
HD2
TYR
PHE
278
283
1.26
1
B
B
OD2
HZ2
ASP
LYS
282
331
1.54
1
A
A
OD2
HG1
ASP
THR
282
313
1.57
1
A
A
O
HG
LYS
SER
294
295
1.57
1
A
A
O
HG
LEU
SER
332
333
1.60
2
A
A
OD2
HZ3
ASP
LYS
282
331
1.54
3
B
B
HB3
HA
SER
ASP
334
359
1.00
3
B
B
HD2
HB
TYR
THR
278
281
1.29
3
A
A
HB
HB2
THR
TYR
313
329
1.31
4
A
A
HB3
HZ
CYS
PHE
299
312
1.27
4
A
A
OD2
HG1
ASP
THR
282
313
1.58
4
A
A
OE1
HZ1
GLU
LYS
323
325
1.60
5
A
A
OD1
HZ2
ASP
LYS
282
331
1.59
6
B
B
HA
HB2
GLN
LEU
310
355
1.17
7
B
B
HG3
H
GLU
GLY
323
324
1.31
7
A
A
OD1
HG1
ASP
THR
282
313
1.58
8
B
B
HA2
HA
GLY
GLU
336
361
1.23
8
A
A
OD1
HZ2
ASP
LYS
282
331
1.51
9
B
B
HA3
HB3
GLY
SER
285
333
1.24
9
B
B
HB
HB3
THR
TYR
313
329
1.29
10
A
B
HZ3
OE2
LYS
GLU
340
287
1.57
10
B
B
HD1
OD1
HIS
ASP
279
280
1.59
12
B
B
HB
HB2
THR
TYR
313
329
1.17
12
A
A
OD1
HZ3
ASP
LYS
282
331
1.58
13
B
B
HA
HB
CYS
VAL
303
307
1.21
13
A
B
HB2
HG
LEU
LEU
288
342
1.33
13
B
B
OD1
HZ2
ASP
LYS
282
331
1.55
13
A
A
HZ1
O
LYS
GLY
325
326
1.60
13
A
B
HZ2
OE1
LYS
GLU
340
286
1.60
13
B
B
HD1
OD1
HIS
ASP
279
280
1.60
14
B
B
HE1
HE3
TYR
LYS
329
331
1.24
14
A
A
HD3
HB2
ARG
MET
308
358
1.26
14
B
B
OD1
HZ3
ASP
LYS
282
331
1.55
14
B
B
HH21
O
ARG
GLU
308
361
1.56
14
A
B
HZ1
OE2
LYS
GLU
340
287
1.59
1
A
CYS
273
-176.84
-81.36
1
A
HIS
274
-146.38
55.37
1
A
SER
275
-47.32
106.07
1
A
ASP
280
72.30
-35.48
1
A
GLU
286
-128.18
-82.24
1
A
SER
295
57.66
110.36
1
A
ALA
306
-165.09
113.80
1
A
PRO
316
-81.59
42.06
1
A
GLN
318
-142.64
-61.20
1
A
ALA
319
-69.59
82.18
1
A
SER
320
-171.88
-57.85
1
A
CYS
321
-150.83
-49.17
1
A
LYS
325
-171.86
-178.52
1
A
SER
333
71.48
93.56
1
A
THR
352
-122.19
-81.83
1
A
LEU
353
62.05
-176.48
1
B
GLU
286
-111.00
-80.61
1
B
ALA
293
-138.79
-68.05
1
B
SER
295
64.07
88.63
1
B
ALA
306
-174.00
22.69
1
B
CYS
309
36.52
85.04
1
B
GLN
318
-173.93
-39.38
1
B
SER
320
-143.97
-78.63
1
B
ASN
322
60.89
-89.66
1
B
LYS
325
-79.63
-165.94
1
B
SER
333
-141.15
-72.63
1
B
SER
334
-24.28
52.79
1
B
ASN
335
-103.60
-149.50
1
B
PRO
338
-72.64
-74.96
1
B
THR
352
-85.62
-112.19
1
B
LEU
353
-137.91
-66.68
2
A
SER
275
-62.11
97.75
2
A
ASP
280
56.93
3.17
2
A
GLU
286
-109.34
-76.21
2
A
SER
295
71.63
113.77
2
A
VAL
307
-72.95
33.57
2
A
GLN
310
-139.79
-56.58
2
A
PRO
316
-90.58
-62.61
2
A
ALA
317
64.93
-83.95
2
A
CYS
321
-175.18
-47.66
2
A
ASN
322
60.18
-101.51
2
A
GLU
323
61.49
-84.23
2
A
LYS
325
-149.60
-82.98
2
A
LEU
353
67.77
-97.73
2
A
ARG
354
-137.76
-30.89
2
B
SER
275
-68.24
99.94
2
B
GLU
286
-128.64
-87.16
2
B
SER
295
65.29
90.10
2
B
VAL
307
-68.69
73.26
2
B
ASN
322
63.15
-176.11
2
B
SER
334
-91.64
-77.63
2
B
THR
339
-105.40
74.02
2
B
LYS
340
-162.51
105.39
2
B
LEU
353
-91.35
-93.76
3
A
HIS
274
72.20
135.21
3
A
HIS
279
-160.84
-149.69
3
A
ASP
280
56.73
16.91
3
A
GLU
286
-105.15
-75.85
3
A
SER
295
68.48
90.62
3
A
VAL
307
-69.59
93.65
3
A
PRO
316
-27.64
-62.28
3
A
ALA
317
-131.46
-73.94
3
A
ALA
319
-79.07
-81.12
3
A
CYS
321
39.03
62.31
3
A
ASN
322
-169.24
-45.57
3
A
GLU
323
63.56
63.90
3
A
ARG
345
-69.72
64.79
3
A
ASN
360
-38.65
91.29
3
B
SER
295
67.99
106.82
3
B
ARG
308
-147.07
29.90
3
B
GLN
310
-131.69
-67.84
3
B
ALA
317
62.40
-171.70
3
B
SER
320
-84.61
41.26
3
B
CYS
321
72.00
126.94
3
B
ASN
322
72.13
100.74
3
B
SER
333
-176.18
41.11
3
B
LEU
353
67.64
177.41
4
A
ASP
280
79.70
-43.52
4
A
SER
295
63.34
77.00
4
A
ALA
317
60.72
-157.78
4
A
GLN
318
-106.31
48.99
4
A
ASN
322
70.43
170.17
4
A
SER
333
-169.86
57.65
4
B
GLU
286
-122.94
-75.06
4
B
SER
295
72.43
110.12
4
B
ARG
308
-164.09
85.30
4
B
GLN
310
-122.86
-56.70
4
B
ALA
317
59.62
-83.16
4
B
GLN
318
64.96
-75.87
4
B
CYS
321
177.83
92.83
4
B
ASN
322
71.15
-67.56
4
B
LEU
353
48.88
-99.73
5
A
HIS
274
66.75
118.19
5
A
SER
275
-59.41
106.42
5
A
GLU
286
-90.23
-65.81
5
A
SER
295
67.71
106.23
5
A
GLN
318
66.05
-85.61
5
A
ALA
319
170.41
-43.80
5
A
SER
320
-170.96
-44.55
5
A
ASN
322
74.80
151.31
5
A
GLU
323
-78.95
25.72
5
B
SER
275
-59.33
102.49
5
B
GLU
286
-119.94
-83.14
5
B
ALA
293
-110.97
-75.57
5
B
SER
295
58.39
105.87
5
B
VAL
307
-68.25
83.59
5
B
GLN
310
-145.67
-36.30
5
B
ALA
317
63.25
-71.58
5
B
GLN
318
67.38
-69.02
5
B
LYS
325
69.85
-179.80
5
B
PRO
338
-55.16
101.93
5
B
THR
352
-111.64
-89.37
5
B
LEU
353
-142.11
-79.69
6
A
ASP
280
72.73
-5.89
6
A
SER
295
62.15
63.91
6
A
VAL
307
-63.95
77.85
6
A
CYS
309
68.46
120.35
6
A
ALA
317
60.20
-85.33
6
A
GLN
318
51.21
71.13
6
A
SER
333
170.64
31.05
6
A
ASN
335
-95.12
-150.49
6
A
PRO
338
-57.38
107.21
6
A
LEU
355
-74.44
20.10
6
B
ASP
280
73.94
-48.49
6
B
SER
295
67.70
111.43
6
B
ALA
319
-141.83
-44.99
6
B
SER
320
-147.57
33.27
6
B
CYS
321
-114.63
-163.93
6
B
ARG
345
-88.65
37.76
6
B
LEU
353
45.13
-76.17
6
B
MET
358
-89.17
36.90
6
B
ASP
359
-101.03
-61.40
7
A
SER
275
-66.03
89.60
7
A
ASP
280
46.95
26.86
7
A
GLU
286
-100.06
-87.93
7
A
SER
295
53.05
106.20
7
A
VAL
307
-77.07
32.96
7
A
GLN
310
-76.47
-87.66
7
A
GLN
318
-68.91
99.18
7
A
CYS
321
73.44
-44.04
7
A
LYS
325
41.08
28.91
7
A
PRO
338
-48.36
107.06
7
A
LEU
353
179.04
-78.86
7
B
HIS
274
73.82
152.47
7
B
GLU
286
-117.19
-81.89
7
B
SER
295
68.52
104.88
7
B
ALA
317
-74.43
-77.77
7
B
GLN
318
65.54
-68.18
7
B
ALA
319
70.55
152.69
7
B
CYS
321
77.57
-67.85
7
B
GLU
323
50.00
-82.71
8
A
SER
275
-60.55
99.03
8
A
GLU
286
-73.22
-72.85
8
A
SER
295
62.67
80.46
8
A
ARG
308
-145.56
28.00
8
A
GLN
310
-138.39
-52.58
8
A
ALA
317
62.13
-81.66
8
A
GLN
318
-92.83
-76.18
8
A
SER
320
-149.91
-71.24
8
A
ASN
322
74.61
153.64
8
A
SER
333
-154.81
30.32
8
A
LEU
353
82.25
137.83
8
A
ARG
354
-65.12
0.90
8
A
ASP
359
-66.84
1.45
8
B
ASP
280
48.04
25.83
8
B
GLU
286
-140.65
-70.10
8
B
SER
295
64.74
86.84
8
B
ALA
306
-90.13
59.37
8
B
VAL
307
-68.07
92.48
8
B
ARG
308
-165.25
38.49
8
B
GLN
318
-98.60
58.75
8
B
SER
320
60.79
123.30
8
B
CYS
321
73.83
-61.99
8
B
GLU
323
-95.09
44.84
8
B
LYS
325
73.68
-178.01
8
B
SER
334
-82.86
-98.37
8
B
ASN
335
-104.35
-79.57
9
A
GLU
286
-121.87
-84.73
9
A
LYS
294
-60.46
-75.84
9
A
HIS
296
-36.32
-71.92
9
A
ALA
306
-177.07
23.61
9
A
CYS
309
57.55
177.79
9
A
GLN
310
-150.74
-46.73
9
A
PRO
316
-75.52
-71.66
9
A
ALA
317
67.48
-21.54
9
A
ALA
319
66.88
-68.15
9
A
SER
320
-146.76
-51.12
9
A
CYS
321
-176.44
26.43
9
A
ASN
322
-153.97
-153.23
9
A
LYS
325
67.36
-70.58
9
A
LEU
353
-59.40
-9.44
9
B
SER
275
-45.99
108.84
9
B
GLU
286
-98.42
-65.78
9
B
SER
295
63.87
82.91
9
B
VAL
307
-69.79
88.33
9
B
ARG
308
-168.82
80.65
9
B
ALA
317
62.74
-85.63
9
B
SER
320
-89.58
-72.07
9
B
CYS
321
179.13
-50.11
9
B
LYS
357
-68.57
0.06
10
A
SER
275
-57.53
99.92
10
A
SER
295
67.93
100.76
10
A
ARG
308
-106.51
40.37
10
A
ALA
317
56.41
-93.52
10
A
GLN
318
64.90
-177.26
10
A
LYS
325
67.67
-164.81
10
A
SER
333
-159.46
84.41
10
A
SER
334
-91.71
-92.42
10
A
ASN
335
-102.89
-68.18
10
A
THR
352
-161.45
-166.59
10
A
LEU
353
71.33
-164.75
10
A
ASP
359
-84.96
46.21
10
B
ASP
280
70.15
-7.75
10
B
GLU
286
-105.39
-62.85
10
B
SER
295
75.34
111.26
10
B
ARG
308
-144.02
16.99
10
B
ALA
317
49.86
90.68
10
B
GLN
318
-149.47
-53.82
10
B
ALA
319
63.92
-99.81
10
B
GLU
323
-116.50
58.71
10
B
LYS
325
63.53
-172.22
10
B
PRO
338
-51.00
106.48
11
A
GLU
286
-99.88
-72.62
11
A
SER
295
67.11
84.65
11
A
ASN
305
-100.77
75.96
11
A
ALA
306
73.28
92.83
11
A
VAL
307
-48.56
100.51
11
A
ALA
317
-109.19
-84.69
11
A
GLN
318
66.29
-64.20
11
A
SER
320
-141.00
35.33
11
A
CYS
321
74.33
110.93
11
A
ASN
322
74.35
-72.67
11
A
LEU
353
-94.72
-66.58
11
B
SER
275
-43.38
108.77
11
B
GLU
286
-139.60
-76.48
11
B
ALA
293
-157.81
-154.13
11
B
SER
295
65.28
93.42
11
B
ALA
306
-162.42
102.09
11
B
VAL
307
-69.87
87.17
11
B
ARG
308
-156.13
42.54
11
B
GLN
310
-139.83
-46.31
11
B
ALA
319
60.86
-157.58
11
B
CYS
321
79.60
-43.23
11
B
LYS
325
68.02
-91.48
12
A
SER
275
-59.94
104.15
12
A
HIS
279
-156.31
-107.19
12
A
ASP
280
54.83
9.45
12
A
THR
281
-160.15
111.19
12
A
GLU
286
-133.80
-93.93
12
A
SER
295
64.01
87.20
12
A
GLN
310
-109.77
-75.11
12
A
ALA
317
52.86
-125.86
12
A
SER
320
-156.78
-70.27
12
A
ARG
345
-104.48
63.66
12
A
ARG
354
-175.73
-63.73
12
B
CYS
273
-139.84
-79.77
12
B
HIS
274
54.54
-94.90
12
B
ASP
280
75.69
-33.87
12
B
GLU
286
-131.49
-95.60
12
B
SER
295
68.09
88.64
12
B
GLN
310
-138.89
-52.36
12
B
SER
320
78.46
132.93
12
B
GLU
323
59.29
-92.86
12
B
LYS
325
56.84
2.93
12
B
LEU
353
-40.82
-80.20
13
A
SER
275
-62.84
97.18
13
A
SER
295
64.97
106.04
13
A
VAL
307
-69.50
73.43
13
A
CYS
321
67.89
-44.65
13
A
THR
352
-89.11
-91.05
13
B
SER
295
65.96
110.74
13
B
ALA
306
-174.96
31.12
13
B
ARG
308
-68.93
99.46
13
B
CYS
321
59.73
-99.15
13
B
GLU
323
63.05
-83.39
13
B
LYS
325
75.47
149.77
13
B
SER
333
104.64
70.88
13
B
ASN
335
-87.07
-149.04
14
A
SER
295
65.02
109.24
14
A
ALA
306
-162.10
111.65
14
A
GLN
310
-131.19
-74.44
14
A
PRO
316
-45.85
-70.13
14
A
ALA
317
69.01
-35.52
14
A
SER
320
-85.68
-87.16
14
A
ASN
322
-172.23
130.70
14
A
LYS
325
67.43
-171.83
14
A
SER
333
-164.81
53.21
14
A
SER
334
-92.54
-83.82
14
A
PRO
338
-66.86
-81.58
14
A
THR
339
-162.68
79.12
14
B
SER
275
-52.89
104.36
14
B
ASP
280
56.59
73.31
14
B
GLU
286
-93.78
-78.81
14
B
SER
295
69.14
100.73
14
B
ARG
308
-151.56
59.34
14
B
ALA
317
-90.25
41.76
14
B
SER
320
-156.11
62.71
14
B
ASN
322
175.07
-33.26
14
B
GLU
323
51.29
87.42
14
B
LYS
325
62.34
-172.36
14
B
THR
352
-100.38
-101.71
14
B
LEU
353
-131.32
-155.98
COAGULATION FACTOR XI (E.C.3.4.21.27)
FXI Apple 4 domain loop-out conformation
1
N
N
1
N
N
A
HIS
296
A
HIS
25
HELX_P
A
LYS
301
A
LYS
30
1
1
6
A
LYS
301
A
LYS
30
HELX_P
A
ALA
306
A
ALA
35
1
2
6
A
ARG
354
A
ARG
83
HELX_P
A
ASN
360
A
ASN
89
5
3
7
B
GLU
297
B
GLU
26
HELX_P
B
ASN
305
B
ASN
34
5
4
9
B
ARG
354
B
ARG
83
HELX_P
B
ASP
359
B
ASP
88
1
5
6
disulf
2.036
A
CYS
273
A
SG
CYS
2
1_555
A
CYS
356
A
SG
CYS
85
1_555
disulf
2.047
A
CYS
299
A
SG
CYS
28
1_555
A
CYS
328
A
SG
CYS
57
1_555
disulf
2.039
A
CYS
303
A
SG
CYS
32
1_555
A
CYS
309
A
SG
CYS
38
1_555
disulf
2.030
A
CYS
321
A
SG
CYS
50
1_555
B
CYS
321
B
SG
CYS
50
1_555
disulf
2.038
B
CYS
273
B
SG
CYS
2
1_555
B
CYS
356
B
SG
CYS
85
1_555
disulf
2.041
B
CYS
299
B
SG
CYS
28
1_555
B
CYS
328
B
SG
CYS
57
1_555
disulf
2.050
B
CYS
303
B
SG
CYS
32
1_555
B
CYS
309
B
SG
CYS
38
1_555
HYDROLASE
PROTEASE, HYDROLASE, GLYCOPROTEIN, POLYMORPHISM, SERINE PROTEASE, HEPARIN-BINDING, DISEASE MUTATION, FXI / BLOOD COAGULATION / PAN DOMAIN /APPLE DOMAIN / BLOOD COAGULATION, ALTERNATIVE SPLICING
FA11_HUMAN
UNP
1
P03951
290
379
2J8L
272
361
P03951
A
1
1
90
290
379
2J8L
272
361
P03951
B
1
1
90
5
2
5
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
SER
276
A
SER
5
A
HIS
279
A
HIS
8
A
ILE
348
A
ILE
77
A
TYR
351
A
TYR
80
A
PHE
311
A
PHE
40
A
THR
315
A
THR
44
A
LYS
327
A
LYS
56
A
LYS
331
A
LYS
60
A
LEU
288
A
LEU
17
A
ALA
292
A
ALA
21
A
ASP
282
A
ASP
11
A
LEU
284
A
LEU
13
A
LYS
340
A
LYS
69
A
LEU
342
A
LEU
71
B
PHE
277
B
PHE
6
B
HIS
279
B
HIS
8
B
ILE
348
B
ILE
77
B
GLY
350
B
GLY
79
B
PHE
311
B
PHE
40
B
TYR
314
B
TYR
43
B
CYS
328
B
CYS
57
B
LEU
332
B
LEU
61
B
GLU
287
B
GLU
16
B
VAL
291
B
VAL
20
B
ASP
282
B
ASP
11
B
LEU
284
B
LEU
13
B
LYS
340
B
LYS
69
B
LEU
342
B
LEU
71
1
P 1